
A drug commonly prescribed to heart attack survivors may not benefit many of them, a new clinical trial has found. Beta-blockers do not appear to reduce the risk of death, a second heart attack or heart failure in people’s whose hearts weren’t damaged by the life-threatening event, results reveal. The findings are expected to overturn… read on > read on >